Key facts
- This page summarizes Peter Greenleaf's Form 3 filing for Pelthos Therapeutics Inc. (CHRO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2025, 21:40.
Peter Greenleaf - 01 Jul 2025 Form 3 Insider Report for Pelthos Therapeutics Inc. (CHRO)
- Reporting relationship
- Director
- Issuer ticker
- CHRO
- Reported as of
- 01 Jul 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Jul 2025, 21:40:07 UTC
- Prior SEC filing
- 04 Mar 2025
- Next SEC filing
- 01 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Greenleaf
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Greenleaf filed Form 3 for Pelthos Therapeutics Inc. (CHRO) on 07 Jul 2025.
Change
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001363683
Primary reporting owner
Greenleaf Peter
- Relationship
- Director
- Address
- C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM
- Signature
- /s/ Peter Greenleaf
- Signature date
- 07 Jul 2025
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
No securities are beneficially owned.